These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Use of Flecainide for the Treatment of Atrial Fibrillation. Echt DS; Ruskin JN Am J Cardiol; 2020 Apr; 125(7):1123-1133. PubMed ID: 32044037 [TBL] [Abstract][Full Text] [Related]
6. Flecainide How and When: A Practical Guide in Supraventricular Arrhythmias. Lavalle C; Magnocavallo M; Straito M; Santini L; Forleo GB; Grimaldi M; Badagliacca R; Lanata L; Ricci RP J Clin Med; 2021 Apr; 10(7):. PubMed ID: 33918105 [TBL] [Abstract][Full Text] [Related]
7. Increased atrial effectiveness of flecainide conferred by altered biophysical properties of sodium channels. O' Brien S; Holmes AP; Johnson DM; Kabir SN; O' Shea C; O' Reilly M; Avezzu A; Reyat JS; Hall AW; Apicella C; Ellinor PT; Niederer S; Tucker NR; Fabritz L; Kirchhof P; Pavlovic D J Mol Cell Cardiol; 2022 May; 166():23-35. PubMed ID: 35114252 [TBL] [Abstract][Full Text] [Related]
8. Ventricular arrhythmia and death among atrial fibrillation patients using anti-arrhythmic drugs. Friberg L Am Heart J; 2018 Nov; 205():118-127. PubMed ID: 30236980 [TBL] [Abstract][Full Text] [Related]
9. Increased capture threshold in permanent His-bundle pacing associated with flecainide. Jiang M; Wasserlauf J; Knight BP; Verma N Pacing Clin Electrophysiol; 2020 Apr; 43(4):360-363. PubMed ID: 32010978 [TBL] [Abstract][Full Text] [Related]